Anxiety and Generalized Anxiety Disorder in Elite Athletes

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Paula Isabel Marques Simões De Freitas

    Autor

Participantes de fora da FMUP

  • Pires, Laura
  • Gomes, Sofia

Unidades de investigação

Abstract

Physical activity is recommended as a strategy for promoting mental health, and it can even be integrated into treatment plans for psychiatric disorders affecting the general population. However, elite athletes are a subpopulation with protective and risk factors inherent to high-level competition and are not shielded from psychiatric symptoms and conditions. The mental health of elite athletes has been the subject of increasing attention, driven in part by the initiatives of the International Olympic Committee and the growing importance of sports psychiatry. This article is a narrative review that provides an overview regarding anxiety, in particular generalized anxiety disorder in elite athletes. Our assessment concluded that competitive anxiety may affect an elite athlete's performance in both harmful and beneficial ways. Assessing the duration, frequency, and functional impact of anxiety symptoms is crucial for ruling out generalized anxiety disorder. Elite athletes do not show a significantly different prevalence of generalized anxiety disorder compared to the general population. Identifying specific protective and risk factors can contribute to adopting more effective preventive and intervention strategies. As in the general population, psychotherapy is recommended for elite athletes as the initial treatment for this condition, combined, if necessary, with pharmacotherapy, according to the World Anti-Doping Agency Code.

Dados da publicação

ISSN/ISSNe:
1646-0758, 1646-0758

Acta Medica Portuguesa  CELOM

Tipo:
Article
Páginas:
-
PubMed:
39546464

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Anxiety; Anxiety Disorders; Athletes; Sports

Projetos associados

Metabolic syndrome is a main determinant of quality of life after metabolic surgery

Investigador Principal: Paula Isabel Marques Simões de Freitas

Estudo Clínico Académico (Metabolic syndrome) . 2023

The impact of integrase inhibitors on the development of hepatic steatosis and fibrosis in HIV-monoinfected patients

Investigador Principal: Paula Isabel Marques Simões de Freitas

Estudo Clínico Académico (Hepatic Steatosis) . 2023

Obesity and Cancer: the profile of a population who underwent bariatric surgery

Investigador Principal: Paula Isabel Marques Simões de Freitas

Estudo Clínico Académico . 2021

The role of gut microbiota-host interaction in obesity and metabolic disturbances

Investigador Principal: Paula Isabel Marques Simões de Freitas

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação